Amy Comander
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
-
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
Papers in
- Oncology 16
- Cancer survivorship and care 9
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 3
- Cancer Risks and Factors 3
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Nadine Tung (4 shared papers)Stuart J. Schnitt (2 shared papers)Judy E. Garber (2 shared papers)Larissa J. Lee (1 shared paper)Brian M. Alexander (1 shared paper)Aditya Bardia (9 shared papers)Tari A. King (2 shared papers)Antonio C. Wolff (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Cancer Research (3 papers)Cancer (2 papers)Supportive Care in Cancer (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
Amy Comander
28 papers receiving 444 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 139
- Oncology 167
- Genetics 89
- Pulmonary and Respiratory Medicine 77
- Genetics 25
Countries citing papers authored by Amy Comander
This map shows the geographic impact of Amy Comander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Comander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Comander more than expected).
Fields of papers citing papers by Amy Comander
This network shows the impact of papers produced by Amy Comander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Comander. The network helps show where Amy Comander may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Comander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 78 | |
| 2 | 2010 | 71 | |
| 3 | 2014 | 63 | |
| 4 | 2011 | 63 | |
| 5 | 2022 | 27 | |
| 6 | 2024 | 21 | |
| 7 | 2021 | 17 | |
| 8 | 2020 | 16 | |
| 9 | 2021 | 14 | |
| 10 | 2020 | 12 | |
| 11 | 2018 | 10 | |
| 12 | 2022 | 9 | |
| 13 | 2023 | 5 | |
| 14 | 2021 | 5 | |
| 15 | 2025 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2025 | 3 |
About Amy Comander
Amy Comander is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Physiology, having authored 32 papers that have together received 451 indexed citations. Recurring topics across this work include Cancer survivorship and care (9 papers), HER2/EGFR in Cancer Research (5 papers), Advanced Breast Cancer Therapies (4 papers), Breast Cancer Treatment Studies (4 papers), BRCA gene mutations in cancer (3 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Risks and Factors (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (139 citations), Oncology (167 citations), Genetics (89 citations), Pulmonary and Respiratory Medicine (77 citations) and Genetics (25 citations). Amy Comander has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Nadine Tung, Stuart J. Schnitt, Judy E. Garber, Larissa J. Lee, Brian M. Alexander, Aditya Bardia, Tari A. King, Antonio C. Wolff, Rachel A. Freedman and Gary H. Lyman. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer, Supportive Care in Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.